None listed
Conditions
Interventions
One tablet of Procaine + Hematoporphyrin will be administered orally once a day
Group name:Group 2 Type of group
A lactose placebo capsule will be given orally once a day
Sponsors
LABORATORIO FARMACEUTICO PERUANO GERMANO S.A. (LAPERGERSA),
Eligibility
Inclusion criteria
Inclusion criteria: Over 55 years old Regular residents of private homes or asylums In good physical and mental health
Exclusion criteria
Exclusion criteria: Significant impairment of brain function. Subjects with acute or chronic diseases that make evaluations impossible or distort. Neoplastic diseases. Subjects under treatment with Procaine, vitamins, sedatives or psychotropics.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Outcome name:For the psychological evaluation, tests specially adapted for the easy comprehension of patients over 55 years of age were included, evaluating the following parameters: the memory of non-personal events, the memory of personal events, the long-term semantic reproduction of sentences, the long-term semantic reproduction of stories. Nonverbal memory was explored with a visual retention test, on hidden objects. Measure:Psycological Evaluation Timepoints:At the beginning of the treatment, at 90 days and at the end of 180 days after the start of treatment ; Outcome name:The emotional state was determined with a checklist of daily activities. It was rated on the scale: O = inadequate, 1 = acceptable, 2 = adequate 3 = very suitable. Measure:Emotional State Timepoints:At the beginning of the treatment, at 90 days and at the end of 180 days after the start of treatment | — |
Countries
Peru
Outcome results
None listed